226.29 - 230.79
161.38 - 242.52
38.50M / 42.21M (Avg.)
34.73 | 6.57
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-1.82%
Negative net income growth while JD stands at 110.39%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-15.46%
Negative yoy D&A while JD is 1.84%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
35.93%
Some yoy growth while JD is negative at -119.48%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-21.49%
Both cut yoy SBC, with JD at -22.55%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-173.18%
Both reduce yoy usage, with JD at -266.59%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
82.74%
AR growth is negative or stable vs. JD's 921.61%, indicating tighter credit discipline. David Dodd would confirm it doesn't hamper sales volume.
-32.80%
Both reduce yoy inventory, with JD at -96.08%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-203.62%
Negative yoy AP while JD is 0.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-98.87%
Both reduce yoy usage, with JD at -383.33%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
10980.53%
Some yoy increase while JD is negative at -1268.28%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-55.28%
Both yoy CFO lines are negative, with JD at -157.47%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-2.31%
Negative yoy CapEx while JD is 43.44%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-520.47%
Both yoy lines negative, with JD at -108.26%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-351.72%
Negative yoy purchasing while JD stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-11.22%
We reduce yoy sales while JD is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-66.23%
We reduce yoy other investing while JD is 151.86%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-41.75%
We reduce yoy invests while JD stands at 144.80%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
83.04%
Debt repayment growth of 83.04% while JD is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.